Features
Choosing Packaging Components for Lyophilised Drug Products
When selecting primary packaging systems for drug products, pharmaceutical manufacturers must ensure that components do not interact with the drug product itself and are applicable for the intended use. For moisture-sensitive lyophilised drug... more »
Oct 1, 2013 in Ingredients & Contract Services
Penn Pharma Officially Opens Contained Manufacturing Facility
A £14 million state-of-the-art facility for the development and manufacture of tablets and capsules containing potent compounds was formally opened on 26 September 2013 by Penn Pharma. An official representative of the Queen, the Lord Lieutenant of.. more »
Sep 30, 2013 in Ingredients & Contract Services
External Clinical Trial Lab Testing Reduces Costs While Promoting Data Quality and Consistency
Covance, one of the world’s largest and most comprehensive drug development companies, has announced the launch of external laboratory management services, a new offering that provides biopharmaceutical companies with a comprehensive management ... more »
Sep 26, 2013 in Ingredients & Contract Services
Range of Off-the-Shelf Testing Methodologies Support Biosimilar Characterisation
BioOutsource, a leading international contract testing organisation (CTO), has consolidated its position as a leading expert in the biological analysis of biosimilar monoclonal antibodies for the biopharmaceutical industry. more »
Sep 23, 2013 in Ingredients & Contract Services
Japan Approves Recipharm’s Manufacture of Cancer Pain Relief Tablet for Kyowa
Recipharm was informed on 20 September 2013 by the R&D-based pharmaceutical company Kyowa Hakko Kirin Co. Ltd. that the Abstral sublingual (under the tongue) tablet has been approved for manufacturing and marketing by Japan's Ministry of Health... more »
Sep 23, 2013 in Ingredients & Contract Services
Merck Millipore Receives Recertification of GMP Compliance for Biodevelopment Centre
Merck Millipore, the Life Science division of Merck, has announced that its Biodevelopment Centre in Martillac, France, has been recertified by the French National Agency for Medicines and Health Products Safety (ANSM), the competent authority of... more »
Sep 23, 2013 in Ingredients & Contract Services
Telormedix Chooses Molecular Profiles to Develop Topical and Oral Psoriasis Products
Pharmaceutical formulation development and manufacturing services provider Molecular Profiles, a subsidiary of Columbia Laboratories, Inc., has been chosen by clinical stage biopharmaceutical company Telormedix SA to develop both topical and solid... more »
Sep 23, 2013 in Ingredients & Contract Services
Butterworth Highlights Extended Contract Analytical Capabilities
Exhibiting at Lab Innovations 2013, Stand G7, Butterworth is a fully independent contract analytical chemistry laboratory, which has been delivering a cost-effective, timely and reliable service for nearly 40 years. more »
Sep 19, 2013 in Ingredients & Contract Services
Capsugel Expands Global Manufacturing for Finished Dosage Forms
Capsugel’s Dosage Form Solutions (DFS) business unit unveiled extensive upgrades and expansions to three of its manufacturing facilities in the US and Europe, deepening the company’s finished dosage form capabilities as part of its LIPIDEX... more »
Sep 19, 2013 in Ingredients & Contract Services
Reusable Shippers Provide Cost Efficiencies for Temperature Controlled Clinical Supplies
Almac’s Clinical Services business unit has announced the addition of refrigerated reusable shippers to its trusted portfolio of solutions for the management and global distribution of temperature controlled clinical supplies. Available as an... more »
Sep 19, 2013 in Ingredients & Contract Services
Aesica Unveils £30 Mn High Capacity Manufacturing Facility for Type 2 Diabetes Medication
Aesica has announced the creation of a new High Capacity Manufacturing Facility following a £30 million investment at its Queenborough, Kent site. The 10,000 m2 expansion has been constructed for the production of a solid dose medication used in... more »
Sep 19, 2013 in Ingredients & Contract Services
Inhalation Sciences Announces US Patent Approval for Precision Dosing System
Inhalation Sciences Sweden, a portfolio company of Karolinska Development, has received US Patent Approval for its flagship technology the PreciseInhale system. more »
Sep 18, 2013 in Ingredients & Contract Services
Supply Chain Programme Now Offers Non-cGMP Ingredients Traceability
Avantor Performance Materials has enhanced its Management of Change (MOC) supply chain alert programme with a new classification to meet the needs of customers wanting full traceability on ingredients not produced under cGMP standards. more »
Sep 18, 2013 in Ingredients & Contract Services
Columbia Laboratories Acquires Molecular Profiles
Columbia Laboratories has acquired Molecular Profiles, a privately-held, cash-flow positive, UK-based pharmaceutical development services company, for cash and Columbia’s Common stock totalling approximately $25.0 million in aggregate. more »
Sep 18, 2013 in Ingredients & Contract Services
$15 Million Investment Drives Cargill's Alginates Business Expansion
Cargill is making a US$15 million investment to upgrade and expand its French alginates production plant — a key part of its strategy to provide a sustainable supply of high quality, competitive alginates for the food and pharmaceutical markets. more »
Sep 12, 2013 in Ingredients & Contract Services
Catalent Drug Delivery Experts Present Collaborative Product Development at EPTM Conference
Dr. Cornell Stamoran, Founding Board Member of the Catalent Applied Drug Delivery Institute, and Terry Robinson, Executive Director of the Institute, are to present at the 52nd Annual Eastern Pharmaceutical Technology Meeting (EPTM). more »
Sep 12, 2013 in Ingredients & Contract Services
EPO Grants Hovione Inhaler Patent
The European Patent Office (EPO) has granted a patent for Hovione’s XCaps, a dry powder inhaler (DPI) that addresses a pulmonary inhalation market need for a very inexpensive device combining high efficiency in powder dispersion with ease of use. more »
Sep 11, 2013 in Ingredients & Contract Services
Demanding Formulations Call for Higher Purity Grade Polysorbates
Avantor Performance Materials has introduced a higher purity Super Refined grade of polysorbate products to improve solubilisation and stability in a variety of biopharmaceutical and small-molecule drug formulations. more »
Sep 11, 2013 in Ingredients & Contract Services
Support Service Speeds Up Nutra and Pharma Product Development
Manufacturers of nutraceutical and pharmaceutical products that want to get new products onto the market more quickly and reliably now have access to a new solution: Boost your NutraPharma project, a service provided by Roquette based on the... more »
Sep 10, 2013 in Ingredients & Contract Services
World’s Pharma Manufacturing Base Moving to India
The India Brand Equity Foundation (IBEF) has compiled its findings and released an overview of the current generics market in India. It predicts that the Indian pharmaceutical market is now at the precipice of the next stage in its development... more »
Aug 20, 2013 in Ingredients & Contract Services
CDMO Delivers Advanced QP Release Services Across Multiple Dosage Forms
Aesica Pharmaceuticals has established a new Quality Assurance team focused on delivering a range of QP services across oral, topical, inhalable and parenteral dosage forms in Investigational Medicinal Products (IMP) clinical trial release... more »
Aug 16, 2013 in Ingredients & Contract Services
Formulation Development and Clinical Testing Service to be Applied to Bronchodilator Therapy
Quotient Clinical has entered a collaboration with Pulmatrix Inc., a biotech company based in Massachusetts, US, to support the development of PUR0200, a new bronchodilator therapy for the treatment of chronic obstructive pulmonary disease and the... more »
Aug 14, 2013 in Ingredients & Contract Services
Biopharma CMO to Produce Monoclonal Antibody for Late Clinical Development and Market
Apeiron Biologics, a biotech company focused on immunologic and biologic therapies against cancer, and Rentschler Biotechnologie, a full service biopharmaceutical contract manufacturer, have jointly announced a partnership agreement to manufacture... more »
Aug 1, 2013 in Ingredients & Contract Services